4
Changes in Ownership
Cue Biopharma, Inc. Filed Acc 0002138368-26-000007
VP, Prin. Accounting Officer sold 5,628 shares at an average $30.09 ($169,324)
- VP, Prin. Accounting Officer acquired 13,647 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Meluzio Michael Vincent · VP, Prin. Accounting Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-08-13 | Exercise or conversion : show line 1 in the form | +13,647 | 54,589 | D | ||
| 2026-08-13 | Sale : show line 2 in the form | −1,519 | $29.37 | $44,613 | 53,070 | D |
| 2026-08-13 | Sale : show line 3 in the form | −4,106 | $30.35 | $124,617 | 48,964 | D |
| 2026-08-13 | Sale : show line 4 in the form | −3 | $31.13 | $93 | 48,961 | D |
| Open-market sales · 5,628 sh · avg $30.09 · $169,324 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-08-13 | Exercise or conversion : show line 5 in the form Common Stock | −13,647 | 27,295 | D |
Loading xslF345X06/form4-08172026_100852.xml…